
Valued at $12.3 billion by market cap, Alexandria Real Estate Equities, Inc. (ARE) is a leading U.S. REIT specializing in Class A/A+ lab and office campuses for life sciences, biotech, and agtech companies. Founded in 1994 and headquartered in Pasadena, California, it owns and develops properties in top innovation clusters, including Boston, San Francisco, San Diego, Seattle, and the Research Triangle.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and ARE perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the REIT industry. Its niche focus on lab space, which is complex to build and less affected by remote work trends, combined with high-barrier markets, long-term leases, and strong tenant demand, provides stable cash flows and growth opportunities.